Migraine Briefs

How does migraine change after 10 years?


 

Key clinical point: After 10 years, a high proportion of migraineurs improve. Reduction in headache frequency, medical follow-up, and nonsmoking are independent factors associated with improvement.

Major finding: After 10 years, 48.2% of patients did not receive a medical follow-up for their migraine. Moreover, 47.4% (180/380) of patients had a decrease of 50% or higher in frequency (defined as improvement), which increased the proportion of episodic migraine (73.7% vs. 87.4%). Factors independently associated with improvement included a baseline frequency of greater than 10 headache days/month (odds ratio [OR], 3.04), having a medical follow-up (OR, 2.45), and nonsmoking (OR, 2.13).

Study details: A 10-year longitudinal study included 1,109 patients with migraine who answered an initial survey (380 completed the survey) and compared initial (2008) and final (2018) data, focusing on baseline prognostic factors of improvement (50% or higher frequency reduction) and no improvement (less than 50% frequency reduction).

Disclosures: No study sponsor was identified. The presenting author had no disclosures. Two coauthors received honoraria from pharmaceutical companies.

Citation: Caronna E et al. Headache. 2020 Feb 18. doi: 10.1111/head.13774.

Recommended Reading

Do urgent care centers use optimal medications for acute migraine?
Migraine ICYMI
Patients with acute migraine can benefit from rimegepant
Migraine ICYMI
Quarterly OnabotulinumtoxinA provides long-lasting prevention of chronic migraine
Migraine ICYMI
Plasma glucose increases during spontaneous migraine attacks
Migraine ICYMI
Migraineurs with aura display higher anger response
Migraine ICYMI
IV eptinezumab holds promise for preventive treatment of episodic migraine
Migraine ICYMI
Galcanezumab is safe and effective for prevention of migraine
Migraine ICYMI
Excess abdominal fat linked to cutaneous allodynia in migraine
Migraine ICYMI
Long-term treatment with lasmiditan reduces migraine-related disability
Migraine ICYMI
CGRP monoclonal antibodies safe and effective for episodic migraine
Migraine ICYMI